Evanko Brian C 4

4 · Cigna Group · Filed Mar 3, 2026

Form 4

Period: 2026-02-27

See Remarks

Transactions

Award
Common Stock, $.01 Par Value
[F1]
2026-02-27+6,428→ 32,897 total
Award
Common Stock, $.01 Par Value
[F2]
2026-02-27+9,787→ 42,684 total
Tax Payment
Common Stock, $.01 Par Value
[F3]
2026-02-27$287.55/sh−2,979$856,611→ 39,705 total
Tax Payment
Common Stock, $.01 Par Value
[F4]
2026-02-27$287.55/sh−1,788$514,139→ 37,917 total
Award
Employee Stock Option (Right to Buy)
[F7]
2026-02-27+15,082→ 15,082 total
Exercise: $287.55From: 2027-03-01Exp: 2036-02-27→ Common Stock, $.01 Par Value (15,082 underlying)

Holdings

Footnotes (7)

[F1]The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
[F2]These restricted shares vest in three equal annual installments beginning March 1, 2027.
[F3]Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
[F4]Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
[F5]Reflects the transfer by the Reporting Person of 25,614 shares of common stock on December 11, 2025 to the Reporting Person's grantor retained annuity trust.
[F6]Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
[F7]This option vests in three equal annual installments beginning March 1, 2027.

Signature

Tyler Gratton, attorney-in-fact|2026-03-02

Documents

1 file